Thomas Board

Thomas Board is a seasoned professional with extensive experience in the pharmaceutical and healthcare sectors, currently serving as Scientific Director at Neurocrine Biosciences since May 2016, specializing in Parkinson’s disease, Gene Therapy, and Rare Diseases. Previous roles include serving as a Senior Medical Science Liaison with a focus on movement disorders at Neurocrine and AbbVie, covering disease states such as Parkinson’s, Multiple Sclerosis, and Alzheimer’s. Thomas also held the position of Senior Clinical Science Manager at Abbott Laboratories, where efforts supported the Immunology Franchise, and managed pharmacy operations at Concord Hospital. The foundational experience includes military service as a Nuclear Machinist Mate in the US Navy. Academic credentials include a Doctor of Pharmacy from Shenandoah University and a Bachelor's Degree in Pharmacy from The Ohio State University.